Loading patent…
AssigneeChrysalis Pharma AG
InventorJohannes SPLEISS
Estimating the term…
Shelf life of soft gelatin capsules comprising a soft gelatin shell encapsulating a pharmaceutical formulation comprising cis-5,8,11,14,17-eicosapentaenoic acid (C20:5 n-3; “EPA”) in free acid form in an amount from 25 wt % to 99 wt % of the formulation and cis-7,10,13,16,19-docosapentaenoic acid (C22:5 n-3; “DPA”) in free acid form in an amount from 1 wt % to 75 wt % of the formulation in which the gelatin component of the shell is Type B gelatin, is improved by replacing up to 75 wt % of the gelatin component with porcine Type A gelatin.
1-37. (canceled)
38:
39:
40:
41:
42:
43:
44:
45:
46:
47:
48:
49:
50:
51:
52:
53:
54:
55:
56:
The soft gelatin capsule as claimed in claim 38, encapsulating from about 100 mg to about 2000 mg of the pharmaceutical formulation.
58:
59:
60:
61:
62:
Dependencies are inferred from the claim text.